Poster Presentations
Method: Disease-specific SE-SD items were developed through expert opinion. These items, general SE scale, Voice Handicap Index (VHI), Consensus Auditory Perceptual Evaluation of Voice (CAPE-V), and Hospital Anxiety and Depression Scale (HADS) were administered to SD patients who presented to University of Washington for botulinum toxin injections over a 6-month period.
Results: Eighty SD patients completed the study with a mean age 58.7 years. The general self-efficacy score (Cronbach's α = .871) was 34.7 ± 3.7 out of 40 and was negatively correlated with VHI (r = -0.22, P = .08), CAPEV (r = -0.14, P = .36), and HADS-A (r = -0.50, P < .001) and HADS-D (r = -0.53, P < .001). Factor analysis was performed and selected 7 items from the general self-efficacy scale and 6 diseasespecific SE-SD items to generate a 13-item disease specific SE-SD scale (Cronbach's α = .913). Disease-specific SE-SD score was 43.9 ± 5.6 out of 52 and is negatively correlated with VHI (r = -0.35, P = .001), CAPE-V (r = -0.29, P = .026), HADS-A (r = -0.49, P < .001), and HADS-D (r = -0.58, P < .001).
Conclusion: SD patients who are established with botulinum toxin injections have a high degree of general SE and diseasespecific SE. Patients with higher SE demonstrate higher subjective and objective vocal quality and lower levels of anxiety and depression. A 13-item disease specific SE-SD scale has been developed.
Laryngology/Broncho-Esophagology Experimental Laryngeal Granuloma in Rats with GERD
Rintaro Shimazu, MD (presenter); Yuichiro Kuratomi, MD, PhD; Akira Inokuchi Objective: Acid reflux and mucosal injury of the larynx may be involved in the development of laryngeal granuloma. This study developed an experimental laryngeal granuloma by mechanical injury to the vocal cord mucosa in rats with chronic acid refluesophagitis to clarify the pathological mechanism of laryngeal granuloma.
Method: An experimental rat model of chronic acid reflux esophagitis was surgically created. A plastic bar was inserted into the trachea of the model rat to mechanically injure the vocal cord mucosa. The pharynx, larynx, and esophagus of these rats were observed histologically every 2 weeks after the operation.
Results:
A granuloma was observed in the vocal cord mucosa of the rat after 2 weeks of the surgery, and this presented the same pathological structure as human laryngeal granuloma. In contrast, only mucosal abrasions and blister formations of the vocal cord mucosa were observed in the control rats without surgery.
Conclusion:
The current results showed both mechanical injury and acid refluwas involved in the development of a laryngeal granuloma.
Laryngology/Broncho-Esophagology incidence of all-Cause Chronic Laryngitis
Daniel J. Stein (presenter); Jacob P. Noordzij, MD Objective: 1) Appreciate the most common causes of chronic laryngitis. 2) Understand the incidence of chronic laryngitis in a primary care population. 3) Describe the demographic profile of patients who present to care for treatment of chronic laryngitis.
Method:
A review identified patients diagnosed with chronic laryngitis among an urban academic medical center primary care population from 2009 to 2010. One hundred subjects with chronic laryngitis were selected, and symptoms, firstvisit treatment, smoking, and demographics were recorded. Incidence was calculated by comparison to an existing database of all cases of idiopathic chronic laryngitis.
Results: Yearly incidence of chronic laryngitis was 19.5 per 1000 people. The 100 subjects consisted of 62 women and 38 men. Race was recorded as black (46), Hispanic (25), white (17), other (12). Age ranged from 20 to 75 years, with a mean of 52.6 years (standard deviation, 12.6 years). Therapies included a proton-pump inhibitor (77%), voice therapy (21%), nasal steroid (15%), anti-histamine (6%), amitriptyline (4%), and no treatment (10%). The most common symptoms reported were cough hoarseness (59%), cough (37%), pain/ soreness (37%), globus (36%), excessive throat clearing (31%), subjective dysphagia (26%), and throat irritation (19%). 92% were seen by an otolaryngologist.
Conclusion:
We found a yearly chronic laryngitis incidence of 19.5 per 1000 people. In an academic setting, most of these will present to otolaryngologists. The majority was treated using proton pump inhibitors. Hoarseness, cough, and pain
